Novel Common Genetic Susceptibility Loci for Colorectal Cancer.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 27 12 2017
revised: 09 03 2018
accepted: 27 04 2018
pubmed: 20 6 2018
medline: 12 3 2020
entrez: 20 6 2018
Statut: ppublish

Résumé

Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk. We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315). In the discovery stage (36 948 case subjects/30 864 control subjects), we identified genetic variants with a minor allele frequency of 1% or greater associated with risk of CRC using logistic regression followed by a fixed-effects inverse variance weighted meta-analysis. All novel independent variants reaching genome-wide statistical significance (two-sided P < 5 × 10-8) were tested for replication in separate European ancestry samples (12 952 case subjects/48 383 control subjects). Next, we examined the generalizability of discovered variants in East Asians, African Americans, and Hispanics (12 085 case subjects/22 083 control subjects). Finally, we examined the contributions of novel risk variants to familial relative risk and examined the prediction capabilities of a polygenic risk score. All statistical tests were two-sided. The discovery GWAS identified 11 variants associated with CRC at P < 5 × 10-8, of which nine (at 4q22.2/5p15.33/5p13.1/6p21.31/6p12.1/10q11.23/12q24.21/16q24.1/20q13.13) independently replicated at a P value of less than .05. Multiethnic follow-up supported the generalizability of discovery findings. These results demonstrated a 14.7% increase in familial relative risk explained by common risk alleles from 10.3% (95% confidence interval [CI] = 7.9% to 13.7%; known variants) to 11.9% (95% CI = 9.2% to 15.5%; known and novel variants). A polygenic risk score identified 4.3% of the population at an odds ratio for developing CRC of at least 2.0. This study provides insight into the architecture of common genetic variation contributing to CRC etiology and improves risk prediction for individualized screening.

Sections du résumé

BACKGROUND
Previous genome-wide association studies (GWAS) have identified 42 loci (P < 5 × 10-8) associated with risk of colorectal cancer (CRC). Expanded consortium efforts facilitating the discovery of additional susceptibility loci may capture unexplained familial risk.
METHODS
We conducted a GWAS in European descent CRC cases and control subjects using a discovery-replication design, followed by examination of novel findings in a multiethnic sample (cumulative n = 163 315). In the discovery stage (36 948 case subjects/30 864 control subjects), we identified genetic variants with a minor allele frequency of 1% or greater associated with risk of CRC using logistic regression followed by a fixed-effects inverse variance weighted meta-analysis. All novel independent variants reaching genome-wide statistical significance (two-sided P < 5 × 10-8) were tested for replication in separate European ancestry samples (12 952 case subjects/48 383 control subjects). Next, we examined the generalizability of discovered variants in East Asians, African Americans, and Hispanics (12 085 case subjects/22 083 control subjects). Finally, we examined the contributions of novel risk variants to familial relative risk and examined the prediction capabilities of a polygenic risk score. All statistical tests were two-sided.
RESULTS
The discovery GWAS identified 11 variants associated with CRC at P < 5 × 10-8, of which nine (at 4q22.2/5p15.33/5p13.1/6p21.31/6p12.1/10q11.23/12q24.21/16q24.1/20q13.13) independently replicated at a P value of less than .05. Multiethnic follow-up supported the generalizability of discovery findings. These results demonstrated a 14.7% increase in familial relative risk explained by common risk alleles from 10.3% (95% confidence interval [CI] = 7.9% to 13.7%; known variants) to 11.9% (95% CI = 9.2% to 15.5%; known and novel variants). A polygenic risk score identified 4.3% of the population at an odds ratio for developing CRC of at least 2.0.
CONCLUSIONS
This study provides insight into the architecture of common genetic variation contributing to CRC etiology and improves risk prediction for individualized screening.

Identifiants

pubmed: 29917119
pii: 5039592
doi: 10.1093/jnci/djy099
pmc: PMC6555904
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

146-157

Subventions

Organisme : NCI NIH HHS
ID : R01 CA195789
Pays : United States
Organisme : NIDDK NIH HHS
ID : K01 DK110267
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK058404
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA137088
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA206110
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA076292
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA081488
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA207371
Pays : United States
Organisme : NIH HHS
ID : S10 OD020069
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA182910
Pays : United States
Organisme : Cancer Research UK
ID : 10119
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : U19 CA148107
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA197350
Pays : United States
Organisme : Cancer Research UK
ID : 10124
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA188214
Pays : United States
Organisme : NCI NIH HHS
ID : U24 CA074794
Pays : United States
Organisme : NCI NIH HHS
ID : UM1 CA173640
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA167551
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA152756
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA071789
Pays : United States

Informations de copyright

© The Author(s) 2018. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Références

N Engl J Med. 2000 Jul 13;343(2):78-85
pubmed: 10891514
Science. 2004 Oct 22;306(5696):636-40
pubmed: 15499007
Nat Genet. 2007 May;39(5):645-9
pubmed: 17401363
Cancer Biol Ther. 2007 Jul;6(7):1143-7
pubmed: 17630503
Nat Genet. 2007 Nov;39(11):1315-7
pubmed: 17934461
Nat Genet. 2008 Dec;40(12):1426-35
pubmed: 19011631
Drug Discov Today Dis Mech. 2007;4(4):293-300
pubmed: 19043597
Nat Genet. 2009 Sep;41(9):986-90
pubmed: 19648918
Am J Hum Genet. 2009 Nov;85(5):679-91
pubmed: 19836008
Nat Genet. 2010 Mar;42(3):224-8
pubmed: 20101243
Nat Biotechnol. 2010 Oct;28(10):1045-8
pubmed: 20944595
Nat Genet. 2010 Nov;42(11):973-7
pubmed: 20972440
Hum Mol Genet. 2011 Jul 15;20(14):2879-88
pubmed: 21531788
Methods Mol Biol. 2011;791:265-86
pubmed: 21913086
Nat Genet. 2011 Oct 30;43(12):1210-4
pubmed: 22037553
Br J Cancer. 2012 Sep 4;107(6):1001-8
pubmed: 22878375
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2
pubmed: 23535731
Hum Mol Genet. 2013 Dec 15;22(24):5048-55
pubmed: 23851122
Carcinogenesis. 2014 Sep;35(9):2039-46
pubmed: 24760461
Nat Genet. 2014 Jun;46(6):533-42
pubmed: 24836286
Nat Genet. 2014 Jul;46(7):731-5
pubmed: 24908248
Hum Mol Genet. 2014 Dec 15;23(24):6616-33
pubmed: 25027329
Nat Commun. 2014 Aug 08;5:4613
pubmed: 25105248
PLoS One. 2014 Nov 06;9(11):e111914
pubmed: 25375357
Gastroenterology. 2015 Jun;148(7):1330-9.e14
pubmed: 25683114
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Nat Commun. 2015 Jul 07;6:7138
pubmed: 26151821
Gut. 2015 Oct;64(10):1623-36
pubmed: 26187503
Hum Genet. 2015 Nov;134(11-12):1249-1262
pubmed: 26404086
Gastroenterology. 2016 Jun;150(7):1633-1645
pubmed: 26965516
Hum Mol Genet. 2016 Jun 1;25(11):2349-2359
pubmed: 27005424
Carcinogenesis. 2016 Jun;37(6):547-556
pubmed: 27207650
Nat Rev Clin Oncol. 2016 Sep;13(9):581-8
pubmed: 27296296
Int J Cancer. 2016 Dec 15;139(12):2655-2670
pubmed: 27459707
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):126-135
pubmed: 27697780

Auteurs

Stephanie L Schmit (SL)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Christopher K Edlund (CK)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Fredrick R Schumacher (FR)

Department of Epidemiology and Biostatistics.

Jian Gong (J)

Public Health Sciences Division.

Tabitha A Harrison (TA)

Public Health Sciences Division.

Jeroen R Huyghe (JR)

Public Health Sciences Division.

Chenxu Qu (C)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
Public Health Sciences Division.

Marilena Melas (M)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

David J Van Den Berg (DJ)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Hansong Wang (H)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI.

Stephanie Tring (S)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
National Cancer Center, Tokyo, Japan.
Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Sarah J Plummer (SJ)

Center for Public Health Genomics, University of Virginia, Charlottesville, VA.

Demetrius Albanes (D)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

M Henar Alonso (MH)

Catalan Institute of Oncology, Bellvitge Biomedical Research Institute.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
University of Barcelona, Barcelona, Spain.

Christopher I Amos (CI)

Department of Biomedical Data Science.

Kristen Anton (K)

Department of Biomedical Data Science.

Aaron K Aragaki (AK)

Public Health Sciences Division.

Volker Arndt (V)

Division of Clinical Epidemiology and Aging Research.

Elizabeth L Barry (EL)

Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NH.

Sonja I Berndt (SI)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Stéphane Bezieau (S)

Public Health Sciences Division.

Stephanie Bien (S)

Centre Hospitalier Universitaire Hotel-Dieu, Nantes, France.

Amanda Bloomer (A)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Juergen Boehm (J)

Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT.

Marie-Christine Boutron-Ruault (MC)

CESP (U1018 INSERM), Facultés de Médecine Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Hermann Brenner (H)

Division of Clinical Epidemiology and Aging Research.
German Cancer Consortium.
National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Stefanie Brezina (S)

Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU), Nantes, France.

Daniel D Buchanan (DD)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Colorectal Oncogenomics Group, Department of Pathology (DDB) and Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.
Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Katja Butterbach (K)

Division of Clinical Epidemiology and Aging Research.

Bette J Caan (BJ)

Division of Research, Kaiser Permanente Medical Care Program of Northern California, Oakland, CA.

Peter T Campbell (PT)

Epidemiology Research Program, American Cancer Society, Atlanta, GA.

Christopher S Carlson (CS)

Public Health Sciences Division.

Jose E Castelao (JE)

Genetic Oncology Unit, Instituto de Investigación Sanitaria Galicia Sur (IISGS), Complejo Hospitalario Universitario de Vigo (CHUVI), SERGAS, Vigo (Pontevedra) Spain.

Andrew T Chan (AT)

Division of Gastroenterology.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA.

Jenny Chang-Claude (J)

Unit of Genetic Epidemiology, Division of Cancer Epidemiology.
Harvard Medical School, Boston, MA.
University Cancer Center Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Iona Cheng (I)

Cancer Prevention Institute of California, Fremont, CA.

Ya-Wen Cheng (YW)

Ph.D. Program of Cancer Research and Drug Discovery.

Lee Soo Chin (LS)

Cancer Science Institute of Singapore, National University of Singapore, Singapore.

James M Church (JM)

Department of Colorectal Surgery, Cleveland Clinic, Cleveland, OH.

Timothy Church (T)

Division of Environmental Health Sciences, University of Minnesota, Minneapolis, MN.

Gerhard A Coetzee (GA)

Van Andel Research Institute, Grand Rapids, MI.

Michelle Cotterchio (M)

Prevention and Cancer Control, Cancer Care Ontario, Toronto, ON, Canada.

Marcia Cruz Correa (M)

Puerto Rico Cancer Center.

Keith R Curtis (KR)

Public Health Sciences Division.

David Duggan (D)

Genetic Basis of Human Disease Division, Translational Genomics Research Institute, Phoenix, AZ.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology.

Dallas English (D)

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.

Edith J M Feskens (EJM)

Division of Human Nutrition, Wageningen University and Research, Wageningen, the Netherlands.

Rocky Fischer (R)

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

Liesel M FitzGerald (LM)

Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.
Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.

Barbara K Fortini (BK)

W.M. Keck Science Department, Claremont Colleges, Claremont, CA.

Lars G Fritsche (LG)

Department of Biostatistics and Center for Statistical Genetics, University of Michigan School of Public Health, Ann Arbor, MI.
K.G. Jebsen Center for Genetic Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Sør-Trøndelag, Norway.

Charles S Fuchs (CS)

Department of Medical Oncology, Dana-Farber Cancer Institute, Brookline, MA.
Department of Medicine, Brigham and Women's Institute, Brookline, MA.

Manuela Gago-Dominguez (M)

Genomic Medicine Group, Galician Foundation of Genomic Medicine, Complejo Hospitalario Universitario de Santiago, Servicio Galego de Saude (SERGAS), Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago De Compostela, Spain.
Moores Cancer Center, University of California San Diego, La Jolla, CA.

Manish Gala (M)

Division of Gastroenterology.

Steven J Gallinger (SJ)

Zane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, Toronto, Ontario, Canada.

W James Gauderman (WJ)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Graham G Giles (GG)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.

Edward L Giovannucci (EL)

Harvard Medical School, Boston, MA.
Channing Division of Network Medicine, Brigham and Women's Institute, Brookline, MA.

Stephanie M Gogarten (SM)

Department of Biostatistics.

Clicerio Gonzalez-Villalpando (C)

Unidad de Investigacion en Diabetes y Riesgo Cardiovascular, Centro de Investigacion en Salud Poblacional, Instituto Nacional de Salud Publica, Cuernavaca, Morelos, Mexico.

Elena M Gonzalez-Villalpando (EM)

Centro de Estudios en Diabetes AC, Mexico City, Mexico.

William M Grady (WM)

Department of Medicine, Division of Gastroenterology, School of Medicine.

Joel K Greenson (JK)

Department of Pathology, University of Michigan, Ann Arbor, MI.

Andrea Gsur (A)

Medical University of Vienna, Department of Medicine I, Institute of Cancer Research, Vienna, Austria.

Marc Gunter (M)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA.

Christopher A Haiman (CA)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Jochen Hampe (J)

Medical Department 1, University Hospital Dresden, TU Dresden, Dresden, Germany.

Sophia Harlid (S)

Department of Radiation Sciences, Oncology, Umea University, Umea, Sweden.

John F Harju (JF)

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

Richard B Hayes (RB)

Division of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY.

Philipp Hofer (P)

Medical University of Vienna, Department of Medicine I, Institute of Cancer Research, Vienna, Austria.

Michael Hoffmeister (M)

Division of Clinical Epidemiology and Aging Research.

John L Hopper (JL)

Centre for MEGA Epidemiology, The University of Melbourne, Carlton, Victoria, Australia.

Shu-Chen Huang (SC)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Jose Maria Huerta (JM)

Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.

Thomas J Hudson (TJ)

AbbVie, Redwood City, CA.
Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

David J Hunter (DJ)

Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, MA.

Gregory E Idos (GE)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Motoki Iwasaki (M)

Division of Epidemiology, Center for Public Health Sciences.

Rebecca D Jackson (RD)

Department of Medicine, Ohio State University, Columbus, OH.

Eric J Jacobs (EJ)

Epidemiology Research Program, American Cancer Society, Atlanta, GA.

Sun Ha Jee (SH)

Department of Epidemiology and Health Promotion, Graduate School of Public Health, Yonsei University, Seoul, South Korea.

Mark A Jenkins (MA)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

Wei-Hua Jia (WH)

State Key Laboratory of Oncology in South China, Cancer Center, Sun Yatsen University, Guangzhou, China.

Shuo Jiao (S)

Public Health Sciences Division.

Amit D Joshi (AD)

Clinical and Translational Epidemiology Unit, Massachusetts General Hospital, Boston, MA.
Program in Genetic Epidemiology and Statistical Genetics, Department of Epidemiology, Harvard School of Public Health, Boston, MA.

Laurence N Kolonel (LN)

Office of Public Health Studies, University of Hawaii Manoa, Honolulu, HI.

Suminori Kono (S)

Service de Génétique Médicale, Centre Hospitalier Universitaire (CHU), Nantes, France.

Charles Kooperberg (C)

Public Health Sciences Division.

Vittorio Krogh (V)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Tilman Kuehn (T)

Division of Cancer Epidemiology.

Sébastien Küry (S)

Department of Preventive Medicine, Kyushu University, Fukuoka, Japan.

Andrea LaCroix (A)

Public Health Sciences Division.

Cecelia A Laurie (CA)

Department of Biostatistics.

Flavio Lejbkowicz (F)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Mathieu Lemire (M)

Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Heinz-Josef Lenz (HJ)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
Department of Medicine, University of Southern California, Los Angeles, CA.

David Levine (D)

Department of Biostatistics.

Christopher I Li (CI)

Translational Research Program, Fred Hutchinson Cancer Research Center, Seattle, WA.

Li Li (L)

Department of Family Medicine and Community Health, Mary Ann Swetland Center for Environmental Health, Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH.

Wolfgang Lieb (W)

Institute of Epidemiology, PopGen Biobank, Christian-Albrechts-University Kiel, Kiel, Germany.

Yi Lin (Y)

Public Health Sciences Division.

Noralane M Lindor (NM)

Department of Health Science Research, Mayo Clinic, Scottsdale, AZ.

Yun-Ru Liu (YR)

Joint Biobank, Office of Human Research.

Fotios Loupakis (F)

Ph.D. Program of Cancer Research and Drug Discovery.

Yingchang Lu (Y)

Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.

Frank Luh (F)

Clalit Health Services National Israeli Cancer Control Center, Haifa, Israel.

Jing Ma (J)

Harvard School of Public Health, Boston, MA.

Christoph Mancao (C)

Genentech, Inc., Basel, Switzerland.

Frank J Manion (FJ)

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

Sanford D Markowitz (SD)

Departments of Medicine and Genetics, Case Comprehensive Cancer Center, Case Western Reserve University, and University Hospitals of Cleveland, Cleveland, OH.

Vicente Martin (V)

Biomedicine Institute (IBIOMED), University of León, León, Spain.

Koichi Matsuda (K)

Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN.

Keitaro Matsuo (K)

Department of Epidemiology, Nagoya University Graduate School of Medicine, Showa-ku, Nagoya, Japan.
Division of Molecular and Clinical Epidemiology, Aichi Cancer Center Research Institute, Chikusa-Ku Nagoya, Japan.

Kevin J McDonnell (KJ)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Caroline E McNeil (CE)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Roger Milne (R)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria, Australia.

Antonio J Molina (AJ)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Research Group on Gene-Environment Interactions and Health, University of León, León, Spain.

Bhramar Mukherjee (B)

University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.

Neil Murphy (N)

Nutrition and Metabolism Section, IARC, Lyon, CEDEX 08, France.

Polly A Newcomb (PA)

Public Health Sciences Division.

Kenneth Offit (K)

Clinical Genetics Service (KO), Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Hanane Omichessan (H)

CESP (U1018 INSERM), Facultés de Médecine Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Cancer Research and Prevention Institute-ISPO, Florence, Italy.

Jesus P Paredes Cotoré (JPP)

Department of Surgery, Complejo Hospitalario Universitario de Santiago (CHUS), Servicio Galego de Saúde (SERGAS), Santiago De Compostela, Spain.

Julyann Pérez-Mayoral (J)

Division of Cancer Biology, University of Puerto Rico, San Juan, Puerto Rico.

Paul D Pharoah (PD)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

John D Potter (JD)

Public Health Sciences Division.

Conghui Qu (C)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
Public Health Sciences Division.

Leon Raskin (L)

Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN.

Gad Rennert (G)

Clalit Health Services National Israeli Cancer Control Center, Haifa, Israel.
Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.
Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Hedy S Rennert (HS)

Clalit Health Services National Israeli Cancer Control Center, Haifa, Israel.
Department of Community Medicine and Epidemiology, Carmel Medical Center, Haifa, Israel.

Bridget M Riggs (BM)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Clemens Schafmayer (C)

Department of Visceral and Thoracic Surgery, University Hospital Schleswig-Holstein, Kiel Campus, Kiel, Germany.

Robert E Schoen (RE)

Department of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, PA.

Thomas A Sellers (TA)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Daniela Seminara (D)

Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Gianluca Severi (G)

CESP (U1018 INSERM), Facultés de Médecine Université Paris-Sud, UVSQ, Université Paris-Saclay, Villejuif, France.
Human Genetics Foundation (HuGeF), Torino, Italy.

Wei Shi (W)

Department of Surgery, Children's Hospital Los Angeles, Los Angeles, CA.

David Shibata (D)

Department of Surgery, University of Tennessee Health Science Center, Memphis, TN.

Xiao-Ou Shu (XO)

Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN.

Erin M Siegel (EM)

Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.

Martha L Slattery (ML)

Department of Internal Medicine, University of Utah Health Sciences Center, Salt Lake City, UT.

Melissa Southey (M)

Colorectal Oncogenomics Group, Department of Pathology (DDB) and Genetic Epidemiology Laboratory, Department of Pathology, University of Melbourne, Melbourne, Victoria, Australia.

Zsofia K Stadler (ZK)

Clinical Genetics Service (KO), Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
Department of Medicine, Weill Cornell Medical Center, New York, NY.

Mariana C Stern (MC)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Sebastian Stintzing (S)

Department of Hematology and Oncology University of Munich (LMU), Munich, Germany.

Darin Taverna (D)

Phoenix College, Phoenix, AZ.

Stephen N Thibodeau (SN)

Mayo Clinic, Rochester, MN.

Duncan C Thomas (DC)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Shoichiro Tsugane (S)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
National Cancer Center, Tokyo, Japan.
Center for Public Health Sciences, National Cancer Center, Tokyo, Japan.

Cornelia M Ulrich (CM)

Huntsman Cancer Institute and Department of Population Health Sciences, University of Utah, Salt Lake City, UT.

Franzel J B van Duijnhoven (FJB)

Division of Human Nutrition, Wageningen University and Research, Wageningen, the Netherlands.

Joseph Vijai (J)

Clinical Genetics Service (KO), Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

Jarmo Virtamo (J)

Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.

Stephanie J Weinstein (SJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.

Emily White (E)

Public Health Sciences Division.

Aung Ko Win (AK)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.

Alicja Wolk (A)

Institute of Environmental Medicine.

Michael Woods (M)

Discipline of Genetics, Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.

Anna H Wu (AH)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Kana Wu (K)

Department of Nutrition, Harvard School of Public Health, Boston, MA.

Yong-Bing Xiang (YB)

State Key Laboratory of Oncogene and Related Genes and Department of Epidemiology, Shanghai Cancer Institute, Shanghai, China.

Yun Yen (Y)

Ph.D. Program of Cancer Research and Drug Discovery.
Department of Medical Oncology and Therapeutic Research, City of Hope National Medical Center, Duarte, CA.

Brent W Zanke (BW)

Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
The University of Ottawa, Ottawa, Ontario, Canada.

Yi-Xin Zeng (YX)

State Key Laboratory of Oncology in South China, Cancer Center, Sun Yatsen University, Guangzhou, China.

Ben Zhang (B)

Division of Noncommunicable Disease Epidemiology and Southwest Hospital Clinical Research Center, Third Military Medical University, Chongqing, China.

Niha Zubair (N)

Public Health Sciences Division.

Sun-Seog Kweon (SS)

Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, South Korea.
South Korea Jeonnam Regional Cancer Center, Chonnam National University Hwasun Hospital, Hwasun, South Korea.

Jane C Figueiredo (JC)

Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Department of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA.

Wei Zheng (W)

Division of Epidemiology, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN.
Vanderbilt-Ingram Cancer Center, Vanderbilt University, Nashville, TN.

Loic Le Marchand (LL)

Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI.

Annika Lindblom (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet Solna, Stockholm, Sweden.

Victor Moreno (V)

Catalan Institute of Oncology, Bellvitge Biomedical Research Institute.
CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
University of Barcelona, Barcelona, Spain.

Ulrike Peters (U)

Department of Epidemiology, School of Public Health, University of Washington, Seattle, WA.

Graham Casey (G)

Center for Public Health Genomics, University of Virginia, Charlottesville, VA.

Li Hsu (L)

Public Health Sciences Division.

David V Conti (DV)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.

Stephen B Gruber (SB)

Department of Preventive Medicine, USC Norris Comprehensive Cancer Center.
Department of Medicine, University of Southern California, Los Angeles, CA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH